Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study (Q44849439)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study |
scientific article published in April 2004 |
Statements
1 reference
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study (English)
1 reference
1 reference
C Katlama
1 reference
A Horban
1 reference
F van Leth
1 reference
P Phanuphak
1 reference
K Ruxrungtham
1 reference
E Baraldi
1 reference
S Miller
1 reference
B Gazzard
1 reference
P Cahn
1 reference
U G Lalloo
1 reference
I P van der Westhuizen
1 reference
D R Malan
1 reference
M A Johnson
1 reference
B R Santos
1 reference
F Mulcahy
1 reference
R Wood
1 reference
G C Levi
1 reference
G Reboredo
1 reference
K Squires
1 reference
I Cassetti
1 reference
D Petit
1 reference
F Raffi
1 reference
J P Dam
1 reference
E Hassink
1 reference
R van Leeuwen
1 reference
P Robinson
1 reference
F W Wit
1 reference
J M A Lange
1 reference
2NN Study team
1 reference
1 April 2004
1 reference
Identifiers
1 reference